Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients

Endocrine

Volumn 46, Issue 3, 2014, Pages 674-677

  Sanchis Gomar, Fabian ^a,b   Alis, Rafael ^c   Pareja Galeano, Helios ^a,b   Sola, Eva ^d   Victor, Victor M ^a,b,d,e   Rocha, Milagros ^b,d,e   Hernández Mijares, Antonio ^a,b,d,e   Romagnoli, Marco ^c  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Instituto Universitario IVI INCLIVA   (Spain)

^c UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^d HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^e Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CYTOKINE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; IRISIN; LIPOPROTEIN A; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; URIC ACID; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; ATHEROGENIC DYSLIPIDEMIA; BODY MASS; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN FUNCTION; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FIBRONECTINS; HUMANS; MALE; MIDDLE AGED; OBESITY;

EID: 84904572364     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0170-9     Document Type: Article

References (9)

1. M.A. Febbraio, B.K. Pedersen, Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exerc. Sport Sci. Rev. 33(3), 114-119 (2005)
2. F. Sanchis-Gomar, C. Perez-Quilis, Irisinemia: a novel concept to coin in clinical medicine? Ann. Nutr. Metab. 63(1-2), 60-61 (2013)
3. P. Bostrom, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, K.A. Rasbach, E.A. Bostrom, J.H. Choi, J.Z. Long, S. Kajimura, M.C. Zingaretti, B.F. Vind, H. Tu, S. Cinti, K. Hojlund, S.P. Gygi, B.M. Spiegelman, A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481(7382), 463-468 (2012)
4. F. Sanchis-Gomar, The skeletal muscle-metabolism axis in prostate-cancer therapy. N. Engl. J. Med. 367(23), 2257-2258 (2013). doi:10.1056/ NEJMc1211955#SA1
5. F. Sanchis-Gomar, G. Lippi, S. Mayero, C. Perez-Quilis, J.L. Garcia-Gimenez, Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes. J. Diabetes 4(3), 196 (2012)
6. F. Sanchis-Gomar, R. Alis, H. Pareja-Galeano, M. Romagnoli, C. Perez-Quilis, Inconsistency in circulating Irisin levels: what is really happening? Horm. Metab. Res. 46, 1-6 (2014)
7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 37(Suppl 1), S81-S90 (2014)
8. J.Y. Huh, G. Panagiotou, V. Mougios, M. Brinkoetter, M.T. Vamvini, B.E. Schneider, C.S. Mantzoros, FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61(12), 1725-1738 (2012)
9. Y.K. Choi, M.K. Kim, K.H. Bae, H.A. Seo, J.Y. Jeong, W.K. Lee, J.G. Kim, I.K. Lee, K.G. Park, Serum irisin levels in new-onset type 2 diabetes. Diabetes Res. Clin. Pract. 100(1), 96-101 (2013)